Article Details
Retrieved on: 2024-02-08 20:26:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
5, 2024, Novartis announced that it intends to acquire MorphoSys, a Germany-based biopharmaceutical company focused on oncology therapeutics, for €68 ...
Article found on: www.biopharminternational.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here